Delivery Order SPE2DB24D1205-SPE2DB25FCYBH
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KLOR-CON M20 tablets. The contract has a ceiling value of $2,750.78 and an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KLOR-CON 10 MEQ TABLET 500S, a pharmaceutical product, with a firm fixed price of $3,531.88 and a completion date of July 2, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,235.67, is for the delivery of KLOR-CON M20 TABLET 500S, a pharmaceutical product. The contract is a Firm Fixed Price type with an ultimate completion date of June 24, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $4,073.68 firm-fixed-price delivery order is for the supply of KLOR-CON M20 TABLET 1000S, a pharmaceutical product, with a period of performance through June 5, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,912.25 firm fixed-price contract is for the delivery of KLOR-CON M20 Tablets, a potassium supplement medication, with a performance period through August 30, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies to supply a wide range of pharmaceutical and medical products to support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of KLOR-CON M20 TABLET 500S, a pharmaceutical product, with a ceiling value of $5,331.17 and a completion date of July 17, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not a set-aside contract....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,192.10 for the supply of potassium chloride 10 MEQ/100 mL solution. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 26, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $4,116.56, is for the delivery of potassium chloride extended-release tablets in 500-count bottles. The contract has a firm-fixed price pricing type and an ultimate completion date of July 1, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation. The contract is for the supply of a pharmaceutical product, KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, with a firm fixed price ceiling value of $1,420.91 and a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of potassium chloride extended-release capsules, a critical medication for various medical conditions. The contract has a ceiling value of $3,641.65 and a completion date of September 16, 2024. There is no set-aside designation...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYBHDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KLOR-CON M20 TABLET 500S, a pharmaceutical product, with a ceiling value of $10,503.72. The contract is for a 4-year performance period, with a completion date of June 27, 2025. This delivery order contract is not set-aside and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to various government agencies, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 6/26/25 |